Patents Assigned to CRC Technology Limited
  • Patent number: 6403767
    Abstract: The present invention provides novel D6 polypeptides and proteins, as well as isolated D6 fusion proteins, antigenic peptides and anti-D6 antibodies. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: June 11, 2002
    Assignees: Millenium Pharmaceuticals, Inc., CRC Technology Limited
    Inventors: Gerard J. Graham, Robert J. Benjamin Nibbs, Jose-Angel Gonzalo, Jose-Carlos Gutierrez-Ramos